Hisamitsu Pharmaceutical Co., Inc. (FRA:HPX)

FRA:HPX Statistics

Total Valuation

FRA:HPX has a market cap or net worth of EUR 1.65 billion. The enterprise value is 1.06 billion.

Market Cap	1.65B
Enterprise Value	1.06B

Important Dates

The next estimated earnings date is Tuesday, January 6, 2026.

Earnings Date	Jan 6, 2026
Ex-Dividend Date	Aug 28, 2025

Share Statistics

Current Share Class	70.30M
Shares Outstanding	n/a
Shares Change (YoY)	-3.19%
Shares Change (QoQ)	-1.55%
Owned by Insiders (%)	0.73%
Owned by Institutions (%)	45.65%
Float	63.40M

Valuation Ratios

The trailing PE ratio is 14.44.

PE Ratio	14.44
Forward PE	n/a
PS Ratio	1.83
PB Ratio	1.06
P/TBV Ratio	1.09
P/FCF Ratio	33.15
P/OCF Ratio	17.16
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.49, with an EV/FCF ratio of 21.17.

EV / Earnings	9.22
EV / Sales	1.23
EV / EBITDA	7.49
EV / EBIT	10.24
EV / FCF	21.17

Financial Position

The company has a current ratio of 3.87, with a Debt / Equity ratio of 0.01.

Current Ratio	3.87
Quick Ratio	3.21
Debt / Equity	0.01
Debt / EBITDA	0.10
Debt / FCF	0.28
Interest Coverage	1,059.89

Financial Efficiency

Return on equity (ROE) is 7.39% and return on invested capital (ROIC) is 4.11%.

Return on Equity (ROE)	7.39%
Return on Assets (ROA)	3.28%
Return on Invested Capital (ROIC)	4.11%
Return on Capital Employed (ROCE)	6.31%
Revenue Per Employee	323,215
Profits Per Employee	40,912
Employee Count	2,799
Asset Turnover	0.45
Inventory Turnover	2.61

Taxes

In the past 12 months, FRA:HPX has paid 31.95 million in taxes.

Income Tax	31.95M
Effective Tax Rate	21.43%

Stock Price Statistics

The stock price has decreased by -10.00% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-10.00%
50-Day Moving Average	22.89
200-Day Moving Average	24.40
Relative Strength Index (RSI)	53.86
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:HPX had revenue of EUR 904.68 million and earned 114.51 million in profits. Earnings per share was 1.57.

Revenue	904.68M
Gross Profit	540.38M
Operating Income	104.83M
Pretax Income	149.05M
Net Income	114.51M
EBITDA	144.64M
EBIT	104.83M
Earnings Per Share (EPS)	1.57

Balance Sheet

The company has 656.84 million in cash and 13.83 million in debt, giving a net cash position of 643.01 million.

Cash & Cash Equivalents	656.84M
Total Debt	13.83M
Net Cash	643.01M
Net Cash Per Share	n/a
Equity (Book Value)	1.56B
Book Value Per Share	21.75
Working Capital	841.97M

Cash Flow

In the last 12 months, operating cash flow was 96.33 million and capital expenditures -46.45 million, giving a free cash flow of 49.87 million.

Operating Cash Flow	96.33M
Capital Expenditures	-46.45M
Free Cash Flow	49.87M
FCF Per Share	n/a

Margins

Gross margin is 59.73%, with operating and profit margins of 11.59% and 12.66%.

Gross Margin	59.73%
Operating Margin	11.59%
Pretax Margin	16.48%
Profit Margin	12.66%
EBITDA Margin	15.99%
EBIT Margin	11.59%
FCF Margin	5.51%

Dividends & Yields

This stock pays an annual dividend of 0.64, which amounts to a dividend yield of 2.72%.

Dividend Per Share	0.64
Dividend Yield	2.72%
Dividend Growth (YoY)	17.82%
Years of Dividend Growth	n/a
Payout Ratio	33.57%
Buyback Yield	3.19%
Shareholder Yield	5.91%
Earnings Yield	6.93%
FCF Yield	3.02%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:HPX has an Altman Z-Score of 4.8 and a Piotroski F-Score of 6.

Altman Z-Score	4.8
Piotroski F-Score	6